MOH — authorised 11 July 2016
- Marketing authorisation holder: SHIRE DEV LLC
- Status: likely_approved
MOH authorised Xiidra on 11 July 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 11 July 2016.
SHIRE DEV LLC holds the UAE marketing authorisation.